基本信息
文件名称:PPARα-agonist-5-生命科学试剂-MCE.pdf
文件大小:667.4 KB
总页数:2 页
更新时间:2025-05-21
总字数:约5.55千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

PPARαagonist5

Cat.No.:HY-173217

分?式:C??H??O?

分?量:368.42

作?靶点:PPAR;Phosphatase

作?通路:CellCycle/DNADamage;MetabolicEnzyme/Protease;Vitamin

DRelated/NuclearReceptor

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性PPARαagonist5是?种?服有效选择性PPARα部分激动剂(EC50:3nM)。PPARαagonist5减少脂质积累

并上调PPARα靶基因,发挥抗脂肪肝作?。PPARαagonist5还通过部分PPARγ激动活性和对蛋?酪氨酸

磷酸酶1B(PTP1B)的轻度抑制(IC50:79.1μM),表现出显著的降?脂和降?糖作?。PPARαagonist5具有

良好的安全性,可?于?脂异常的2型糖尿病的研究[1]。

IC50TargetPPARαPPAR-γPPARδ

3nM(EC50)1.66μM(EC50)25μM(EC50)

体外研究PPARαagonist5(Compound(S)-2)selectivelyagonizesPPARαinHepG2cells(EC50:3nM),is

approximately550-foldmoreactiveagainstPPARαthanagainstPPARγ(EC50:1.66μM),andhasno

significantactivityagainstPPARδ[1].

PPARαagonist5(0.025-25μM,24h/15days)significantlyreduceslipidaccumulationinducedbyoleicacid

inHepaRGcellsandupregulatedPPARαtargetgenesassociatedwithfattyacidoxidation,indicatingth